Toronto - Delayed Quote CAD
Oncolytics Biotech Inc. (ONC.TO)
0.7100
-0.0100
(-1.39%)
At close: May 14 at 3:59:10 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 3.76M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| Andrews (Patricia S.) Director of Issuer | -- | Direct | -- | Apr 21, 2025 |
| Brown (Deborah M) Director of Issuer | -- | Direct | -- | Apr 21, 2025 |
| Holtham, Angela Frances Director of Issuer | -- | Direct | -- | Apr 21, 2025 |
| Parsons (James T CPA) Director of Issuer | -- | Direct | -- | Apr 21, 2025 |
| Pisano (Wayne) Director of Issuer | -- | Direct | -- | Apr 21, 2025 |
| Seizinger (Bernd R.) Director of Issuer | -- | Direct | -- | Apr 21, 2025 |
| Coffey (Matthew) Director of Issuer | -- | Direct | -- | Jan 29, 2025 |
| Degois (Christophe) Senior Officer of Issuer | -- | Direct | -- | Jan 29, 2025 |
| Hagerman (Allison) Senior Officer of Issuer | -- | Direct | -- | Jan 29, 2025 |
| Heineman (Thomas Ph.D.) Senior Officer of Issuer | -- | Direct | -- | Jan 29, 2025 |
| Levin (Amy G) Senior Officer of Issuer | -- | Direct | -- | Jan 29, 2025 |
| Look (Kirk) Senior Officer of Issuer | -- | Direct | -- | Jan 29, 2025 |
| Coffey (Matthew) Director of Issuer | -- | Direct | -- | Dec 9, 2024 |
| Hagerman (Allison) Senior Officer of Issuer | -- | Direct | -- | Dec 9, 2024 |
| Heineman (Thomas Ph.D.) Senior Officer of Issuer | -- | Direct | -- | Dec 9, 2024 |
| Levin (Amy G) Senior Officer of Issuer | -- | Direct | -- | Dec 9, 2024 |
| Look (Kirk) Senior Officer of Issuer | -- | Direct | -- | Dec 9, 2024 |
| Coffey (Matthew) Director of Issuer | -- | Direct | -- | Nov 27, 2024 |
| Hagerman (Allison) Senior Officer of Issuer | Exercise of rights at price 1401.48 per share. | Direct | 2,755,315 | Nov 27, 2024 |
| Heineman (Thomas Ph.D.) Senior Officer of Issuer | -- | Direct | -- | Nov 27, 2024 |
| Levin (Amy G) Senior Officer of Issuer | -- | Direct | -- | Nov 27, 2024 |
| Look (Kirk) Senior Officer of Issuer | -- | Direct | -- | Nov 27, 2024 |
| Degois (Christophe) Senior Officer of Issuer | -- | Direct | -- | May 28, 2024 |
Related Tickers
MDNA.TO Medicenna Therapeutics Corp.
1.0500
-4.55%
TH.TO Theratechnologies Inc.
3.5100
-3.84%
BCT.TO BriaCell Therapeutics Corp.
4.2400
-4.72%
APS.TO Aptose Biosciences Inc.
2.3500
-7.48%
CYBN.NE Cybin Inc.
8.90
-2.52%
RVX.TO Resverlogix Corp.
0.0400
-11.11%
IMCR Immunocore Holdings plc
27.69
-3.01%
MDMA.CN Pharmala Biotech Holdings Inc.
0.1300
-10.34%
GLAB.CN Gemina Laboratories Ltd.
0.8900
+1.14%
RLMD Relmada Therapeutics, Inc.
0.4300
+10.26%